Neuropsychologist - Healthcare Executive Advisory Board Member

About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America uses Artificial Intelligence (AI) + Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and brain fog from Long COVID. This is not about research. This is about treating patients. ATCA goes beyond diagnosing Alzheimer’s and dementia to uncover and address root causes through our innovative treatment protocols. Our multidisciplinary team, which includes top business executives and medical professionals with expertise in virtual reality and artificial intelligence, is leading the rollout of ATCA Clinics across the U.S. Why Now? Immediate Revenue: ATCA is expanding to a multi-clinic organisation incorporating a new prime location...We're Launching Our New Clinic in Palm Beach Gardens, Florida. The Alzheimer's Treatment Centers of America ATCA clinic Palm Beach Gardens/Jupiter is located on the first floor of a two storey building with the Cleveland Clinic as a neighboring tenant. It is located in one of the most affluent areas and has replaced a prior urgent care space which has resulted in high levels of uptake with appointments already booked as far as March. In-Network with Insurance: ATCA treatments are covered by Medicare, Medicare Advantage, and most major healthcare insurance providers. Proven Results: In a study using the AI protocol implemented by ATCA, 75% of patients with mild cognitive impairment experienced no further decline. FDA-Approved Treatment: Includes TB006, which is FDA-approved for compassionate use and has the potential to reverse dementias, including Alzheimer’s. Physician-Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. See our Medical Advisory Board:

https://atca.ai/medical-advisory-board/ Key Achievements Proven AI Protocol: Combines cutting-edge AI and precision medicine to deliver highly personalized treatment solutions. Scalable Model: Clinics are designed to deliver a 44% EBITDA margin, supported by strong unit economics. Market Opportunity: The U.S. Alzheimer’s treatment market is valued at $355 billion, with a global opportunity of $1.5 trillion. Research-Driven Care: Clinics also serve as micro-research facilities to advance innovation and generate future revenue streams. Neuropsychologist Job Description ATCA is seeking an accomplished Neuropsychologist to join its Medical Advisory Board and support the clinical and strategic expansion of a next-generation treatment model for Alzheimer’s disease, dementia, and cognitive decline. This role is designed for senior neuropsychologists who specialize in the assessment, interpretation, and longitudinal tracking of cognitive function across neurodegenerative conditions. As a Neuropsychologist Advisor, you will help guide how cognitive testing, behavioral assessment, and neurocognitive data are integrated into ATCA’s AI-driven precision medicine approach. You will work closely with ATCA’s executive leadership, neurologists, psychiatrists, geriatricians, and data science teams to refine diagnostic frameworks, validate treatment impact, and ensure cognitive outcomes are accurately measured and continuously improved across the clinic network. Responsibilities Include Clinical Strategy & Oversight: Provide expert guidance on neuropsychological evaluation, cognitive testing, and interpretation of cognitive decline in patients with Alzheimer’s disease, dementia, and mild cognitive impairment. Cognitive Assessment Integration: Advise on the selection, validation, and deployment of cognitive assessments used to inform diagnosis, treatment planning, and longitudinal outcome tracking. Precision Medicine Integration: Guide how neurocognitive test results, behavioral data, and longitudinal cognitive trends should inform AI-assisted treatment decisions within ATCA’s precision medicine platform. Outcomes Measurement & Validation: Support the development of standardized cognitive outcome measures to assess treatment effectiveness across ATCA clinics. Quality & Outcomes Review: Review aggregated, de-identified cognitive outcome data to ensure reliability, validity, and continuous improvement in neuropsychological care delivery. Interdisciplinary Collaboration: Collaborate with physicians, technologists, and executive leadership to align cognitive assessment with clinical workflows and operational scalability. Innovation Support: Provide insight into emerging neuropsychological research, digital cognitive assessment tools, and novel outcome measurement approaches that may enhance ATCA’s clinical offerings.

Why Join Us? Transform Patient Outcomes: Help advance a model of Alzheimer’s care that prioritizes early detection, prevention, and coordinated primary care involvement. Influence National Care Delivery: Play a meaningful role in shaping how primary care–informed cognitive care is delivered across a growing network of clinics nationwide. Collaborate with Leaders: Work alongside a world-class team of physicians, scientists, AI experts, and healthcare executives. Be Part of a Defining Moment: Join ATCA at a critical stage of expansion where primary care leadership directly impacts growth, outcomes, and legacy. Compensation / Perks Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission. Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role. Equal Opportunity Commitment ATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer’s treatment.